{"id":109192,"date":"2023-09-06T17:45:04","date_gmt":"2023-09-06T12:15:04","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=109192"},"modified":"2023-09-06T17:45:40","modified_gmt":"2023-09-06T12:15:40","slug":"multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/","title":{"rendered":"Multibagger stock hits 20% upper circuit after board approves the sale of its API business\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-279552354\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of the second largest drug manufacturers in north India soared 20 percent after the company board approved the slump sale of the Active Pharmaceuticals Ingredients business.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2308472036\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>On Wednesday, <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/INDSWFTLAB\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Ind-Swift Laboratories Ltd<\/a><\/strong>, a small-cap stock with a market capitalization of Rs 729 crore, touched a 20 percent upper circuit on the Exchange for Rs 123.40 per share.\u00a0<\/p><p>According to the company\u2019s exchange filing, The Ind-Swift Laboratories Board of Directors has approved the slump sale of Active Pharmaceutical Ingredients and the CRAMS Business to Synthimed Labs for a total enterprise value of Rs 1,650 crore. The transaction&#8217;s equity value is Rs 850 crore, with an approximate debt of Rs 800 crore, subject to other adjustments in accordance with the terms of the Business Transfer Agreement (BTA).&nbsp;<\/p><p>The company&#8217;s revenue from the API Business was Rs 1151.95 Crores for the fiscal year ended March 31, 2023, accounting for 96% of the Company&#8217;s consolidated revenue. API Business&#8217;s net worth was Rs 361.89 crores as of March 31, 2023.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-2893969264\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The company\u2019s shares have delivered multibagger returns of 108 percent over a year. A Rs 1 lakh investment in the company would be worth Rs. 2.08 lakh after a year.&nbsp;<\/p><p>For the most recent fiscal year\u2019s report, the company margins grew modestly, resulting in a net profit margin of 3.96 percent and a return on capital employed of 17 percent.&nbsp;<\/p><p>The Company\u2019s revenue climbed by 10 percent year on year, rising from Rs 280 crore in Q1FY23 to Rs 310 crore in Q1FY24. During the same time period, net profit fell by 10 percent from Rs 19 crore to Rs 17 crore.&nbsp;<\/p><p>According to the latest shareholding pattern, the promoters own 42 percent of the company, Domestic institutional investors hold 19.49 percent and retail investors hold 38.44 percent stake.&nbsp;<\/p><p>Ind-Swift Laboratories Ltd is the manufacturer and exporter of APIs and Advanced Intermediates. The Company caters to the API needs of Regulated and Soft Regulated Markets.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Omkar Chitnis<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-3763308553\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-3220313211\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of the second largest drug manufacturers in north India soared 20 percent after the company board approved the slump sale of the Active Pharmaceuticals Ingredients business.&nbsp; On Wednesday, Ind-Swift Laboratories Ltd, a small-cap stock with a market capitalization of Rs 729 crore, touched a 20 percent upper circuit on the Exchange for Rs 123.40 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":62638,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[11774,11776,948,936],"class_list":["post-109192","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-ind-swift-laboratories-share-price","tag-ind-swift-laboratories-upper-circuit","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Multibagger stock hits 20% upper circuit after board approves the sale of its API business\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of the second largest drug manufacturers in north India soared 20 percent after the company board approved the slump sale of the Active Pharmaceuticals Ingredients business.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Multibagger stock hits 20% upper circuit after board approves the sale of its API business\u00a0\" \/>\n<meta property=\"og:description\" content=\"Shares of the second largest drug manufacturers in north India soared 20 percent after the company board approved the slump sale of the Active Pharmaceuticals Ingredients business.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-06T12:15:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-06T12:15:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/09\/Market-1985-Cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/\",\"url\":\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/\",\"name\":\"Multibagger stock hits 20% upper circuit after board approves the sale of its API business\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/09\/Market-1985-Cover-image.jpg\",\"datePublished\":\"2023-09-06T12:15:04+00:00\",\"dateModified\":\"2023-09-06T12:15:40+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of the second largest drug manufacturers in north India soared 20 percent after the company board approved the slump sale of the Active Pharmaceuticals Ingredients business.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/09\/Market-1985-Cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/09\/Market-1985-Cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Multibagger stock hits 20% upper circuit after board approves the sale of its API business\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Multibagger stock hits 20% upper circuit after board approves the sale of its API business\u00a0 - Trade Brains Features","description":"Shares of the second largest drug manufacturers in north India soared 20 percent after the company board approved the slump sale of the Active Pharmaceuticals Ingredients business.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/","og_locale":"en_US","og_type":"article","og_title":"Multibagger stock hits 20% upper circuit after board approves the sale of its API business\u00a0","og_description":"Shares of the second largest drug manufacturers in north India soared 20 percent after the company board approved the slump sale of the Active Pharmaceuticals Ingredients business.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-09-06T12:15:04+00:00","article_modified_time":"2023-09-06T12:15:40+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/09\/Market-1985-Cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/","url":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/","name":"Multibagger stock hits 20% upper circuit after board approves the sale of its API business\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/09\/Market-1985-Cover-image.jpg","datePublished":"2023-09-06T12:15:04+00:00","dateModified":"2023-09-06T12:15:40+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of the second largest drug manufacturers in north India soared 20 percent after the company board approved the slump sale of the Active Pharmaceuticals Ingredients business.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/09\/Market-1985-Cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/09\/Market-1985-Cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/multibagger-stock-hits-20-upper-circuit-after-board-approved-the-sale-of-the-api-business\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Multibagger stock hits 20% upper circuit after board approves the sale of its API business\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/109192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=109192"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/109192\/revisions"}],"predecessor-version":[{"id":109194,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/109192\/revisions\/109194"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/62638"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=109192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=109192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=109192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}